September 23, 2014 7:26 PM ET

Health Care Technology

Company Overview of MEDai, Inc.

Company Overview

MEDai, Inc. provides clinical and financial intelligence solutions primarily for payers and provider markets. The company provides Pinpoint Review, which predicts patient needs and provides staff alerts; Pinpoint Quality that monitors outcomes and physician performance to identify opportunities for clinical, financial, and operational improvement; and Pinpoint Compliance, which delivers regulatory reports for performance improvement. It also offers Risk Navigator Clinical, a predictive tool that identifies and manages high-risk populations to improve patient quality; Risk Navigator Guidelines that monitors member and physician compliance with evidence-based guidelines; and Risk Navigator Per...

4901 Vineland Road

Millenia Park One

Suite 450

Orlando, FL 32811

United States

Founded in 1988





Key Executives for MEDai, Inc.

Co-Founder and Executive Vice President
Director of Finance
Chief Medical Officer
Director of Product Strategy
Compensation as of Fiscal Year 2014.

MEDai, Inc. Key Developments

Caradigm and MEDai Align to Help Healthcare Organizations Manage Risk, Optimize Care and Improve Population Health

Caradigm announced it has signed an agreement with MEDai. Under the agreement, Caradigm will enrich its population health solutions with the predictive clinical analytics capabilities of MEDai's solution, enabling customers to stratify patient populations according to severity, disease state, cost or risk profile. This will allow risk-bearing organizations to use their network of resources to focus care on those who will benefit most, helping create a positive impact on overall health outcomes and total cost of care. When coupled with Caradigm(R) Care Management software, providers can develop personalized care plans that specify problems, goals and interventions, and manage patients and conditions through timely interventions enabled by near real-time, event-based alerts.

AmeriBen/IEC Group Chooses Elsevier's MEDai Inc.'s Risk Navigator Clinical(R) Software

Elsevier's MEDai, Inc. announced a new licensing agreement with AmeriBen/IEC Group for MEDai's Risk Navigator Clinical(R) software. MEDai's Risk Navigator Clinical will assist AmeriBen, which manages more than 150,000 lives, in its population management. MEDai will provide AmeriBen with Risk Navigator Clinical, a robust solution to analyze and understand their care populations, and execute on strategies to improve the quality of care, reduce costs and waste, and ultimately impact health for their members. Risk Navigator Clinical leverages predictive analytics to transform raw data into intelligent insight that payers can use to allocate resources efficiently and intervene before adverse, costly outcomes occur. Through an easy-to-use web interface, Risk Navigator's results outline areas that provide the potential for intervention and management, allowing stakeholders to improve operations and set competitive premium rates.

Similar Private Companies By Industry

Company Name Region
Agilum Healthcare Intelligence United States
EngagePoint, Inc. United States
Angel Eye Camera Systems, LLC United States
NoteSwift, Inc. United States
Teges Corporation United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDai, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at